Sellas Life Sciences Group Revenue, Growth & Competitor Profile

DBA GALENA BIOPHARMA, INC.

Company Profile & Annual Report for Sellas Life Sciences Group

Access the complete profile.

Sellas Life Sciences Group Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	7 Times Square Suite 2503 New York, NY 10036

Note: Revenues for privately held companies are statistical evaluations.


Sellas Life Sciences Group's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sellas Life Sciences Group's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Sellas Life Sciences Group is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Sellas Life Sciences Group Annual Revenue and Growth Rate

Sellas Life Sciences Group	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sellas Life Sciences Group's revenues are gauged from an analysis of company filings.

Sellas Life Sciences Group's Income Statement (based on Industry Averages)

Sellas Life Sciences Group P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Sellas Life Sciences Group is developing and marketing. Sellas Life Sciences Group doesn't have any recent trademark applications, indicating Sellas Life Sciences Group is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NEUVAX pharmaceutical preparations and vaccines for the treatment of cancer	03/17/2011
ABSTRAL Pharmaceutical and medicinal preparations and substances for the treatment of [metabolic disorders, hormone deficiencies, skin diseases, skin disorders, bone diseases, bone disorders, sexually transmitted diseases, diseases of the central nervous system, cancer, microbial conditions and infections, rectal conditions, rectal diseases and rectal disorders, vitamin and mineral deficiencies, pain, gastro-intestinal conditions, and cardiovascular conditions]; pharmaceutical preparations[, substances and gels for hormone replacement; sanitary preparations for medical use; dietetic foods and dietetic food supplements adapted for medical use; medical plasters; materials for dressings, namely, burn dressings, surgical dressings, and wound dressings; gauzes and bandages for dressings; transdermal patches containing pharmaceutical preparation for the treatment of metabolic disorders, hormone deficiencies, skin diseases, skin disorders, bone diseases, bone disorders, sexually transmitted diseases, diseases of the central nervous system, cancer, microbial conditions and infections, rectal conditions, rectal diseases and rectal disorders, vitamin and mineral deficiencies], pain[, gastro-intestinal conditions, and cardiovascular conditions]	02/27/2007

See all trademarks and details in the Full Report.

Market Share of Sellas Life Sciences Group's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sellas Life Sciences Group, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Sellas Life Sciences Group. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ITI	New York, NY	100
STEMLINE THERAPEUTICS	New York, NY	67
TG THERAPEUTICS	New York, NY	58
POPULATION COUNCIL	New York, NY	53
NEW YORK GENOME CENTER	New York, NY	33
OXFORD NANOPORE TECHNOLOGIES	New York, NY	23

Future Competition: Sellas Life Sciences Group's Fastest Growing Competitors

These companies are in the same general field as Sellas Life Sciences Group and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)